FDA Issues Draft Guidance For Clinical Studies On Psychedelics
The FDA recently issued a draft guidance for clinical studies on psychedelics, a move that has the potential to transform the field of mental health treatment. This guidance marks a major milestone in the development of psychedelics as a potential treatment for a variety of mental health conditions, from depression and anxiety to PTSD and … Read more